Risk factors for ischemic optic neuropathy after cardiopulmonary bypass: A matched case/control study

被引:69
作者
Nuttall, GA [5 ]
Garrity, JA
Dearani, JA
Abel, MD
Schroeder, DR
Mullany, CJ
机构
[1] Mayo Clin & Mayo Grad Sch Med, Dept Anesthesiol, Rochester, MN USA
[2] Mayo Clin & Mayo Grad Sch Med, Dept Ophthalmol, Rochester, MN USA
[3] Mayo Clin & Mayo Grad Sch Med, Dept Surg, Rochester, MN USA
[4] Mayo Clin, Dept Biostat, Rochester, MN USA
[5] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA
关键词
D O I
10.1097/00000539-200112000-00012
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Visual loss (acuity or field) secondary to ischemic optic neuropathy (ION) is a rare but devastating complication of cardiac surgery involving cardiopulmonary bypass (CPB). We determined clinical features and risk factors for ION by a retrospective time-matched, case-control study. ION was identified in 17 (0.06%) patients out of 27,915 patients who underwent CPB between January 1, 1976, and December 31, 1994. For each ION patient, two patients who underwent CPB exactly 2 wk before the ION patient were selected as controls. Data were analyzed by using conditional logistic regression with the 1:2 matched-set feature of 17 cases and 34 controls. Two-tailed P values less than or equal to0.05 were considered significant. From bivariate analysis, smaller minimum postoperative hemoglobin concentration (odds ratio [OR] = 1.9, P = 0.047) and the presence of atherosclerotic vascular disease (OR = 7.0, P = 0.026) were found to be independently associated with ION after CPB, as were smaller minimum postoperative hemoglobin concentration (OR = 2.2, P = 0.027) and preoperative angiogram within 48 h of surgery (OR = 7.2, P = 0.042). In ION patients, 13 (76.5%) of 17 experienced a minimum postoperative hemoglobin value of <8.5 g/dL, whereas only 14 (41.2%) of 34 control patients experienced values <8.5 g/dL.
引用
收藏
页码:1410 / 1416
页数:7
相关论文
共 32 条
[1]  
[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI DOI 10.1164/rccm.200405-644ST
[2]  
BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700
[3]  
BLAUTH CI, 1988, J THORAC CARDIOV SUR, V95, P668
[4]   Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome [J].
Bracey, AW ;
Radovancevic, R ;
Riggs, SA ;
Houston, S ;
Cozart, H ;
Vaughn, WK ;
Radovancevic, B ;
McAllister, HA ;
Cooley, DA .
TRANSFUSION, 1999, 39 (10) :1070-1077
[5]   CENTRAL NERVOUS-SYSTEM COMPLICATIONS OF CORONARY-ARTERY BYPASS GRAFT-SURGERY - PROSPECTIVE ANALYSIS OF 421 PATIENTS [J].
BREUER, AC ;
FURLAN, AJ ;
HANSON, MR ;
LEDERMAN, RJ ;
LOOP, FD ;
COSGROVE, DM ;
GREENSTREET, RL ;
ESTAFANOUS, FG .
STROKE, 1983, 14 (05) :682-687
[6]  
BROWN MJK, 1994, VA LAW REV, V80, P7
[7]   OPTIC DISK RISK-FACTORS FOR NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY [J].
BURDE, RM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1993, 116 (06) :759-764
[8]   BRAIN EMBOLIC PHENOMENA ASSOCIATED WITH CARDIOPULMONARY BYPASS [J].
CHALLA, VR ;
MOODY, DM ;
TROOST, BT .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 117 (1-2) :224-231
[9]  
*COMM PROF HOSP AC, 1973, H ICDA AD ICDA
[10]   Blood loss from coronary angiography increases transfusion requirements for coronary artery bypass graft surgery [J].
Ereth, MH ;
Nuttall, GA ;
Orszulak, TA ;
Santrach, PJ ;
Cooney, WP ;
Oliver, WC .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2000, 14 (02) :177-181